Earnings Call · Q1 FY2024·2024-05-14

Q1 24EPS +19.50%·Rev n/aQ4 23EPS -21.95%·Rev n/aQ3 23EPS -16.67%·Rev n/aQ2 23EPS -9.31%·Rev n/a⚠ consensus missing

Longeveron Inc. LGVN

Derek Cole — Investor Relations

Wael Hashad — Chief Executive Officer

Nataliya Agafonova — Chief Scientific Officer

Lisa Locklear — Chief Financial Officer

Joshua Hare — Chief Medical Officer

−3.6%1d on move date−4.8% vs SPY3d−7.9%5d−14.4%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more LGVN calls or request research access.

More LGVN calls Browse calls Request research access